Trial Profile
Comparative Study of Natural Micronized Progestrone and Gonadotropin-Releasing Hormone Agonist in the Control of Bleeding During Hysterescopic Myomectomy in Women With Abnormal Uterine Bleeding
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs LHRH receptor agonists (Primary) ; Progesterone (Primary)
- Indications Uterine haemorrhage
- Focus Therapeutic Use
- 18 Jun 2018 New trial record